8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof

1. A compound according to formula I

or a pharmaceutically acceptable salt thereof wherein

R1 is one or two groups independently selected from hydrogen, hydroxy, (1-6C)alkoxy, (1-6C)alkyl, halogen or cyano;

R2 is H or (1-6C)alkyl;

R3 is

(R31)(R32)CH—O; or

R3 is (3-7C)cycloalkoxy which is optionally substituted with one or more substituents selected from fluoro or hydroxy; or

R3 is heteroaryl, which is optionally substituted with one or more substituents selected from R34, R35, R36, halogen, hydroxy or cyano;

R31 is H or (1-5C)alkyl optionally substituted with one or more fluoro, hydroxy or (1-6C)alkoxy;

R32 is (1-5C)alkyl optionally substituted with one or more fluoro;

R34 is (1-6C)alkyl optionally substituted with one or more fluoro;

R35 is (1-6C)alkoxy optionally substituted with one or more fluoro;

R36 is hydrogen or (1-6C)alkyl optionally substituted with one or more fluoro;

or

R4 is (1-4C)alkyl, optionally substituted independently by one or more substituents selected from R8, fluoro or hydroxy;

wherein

m is 1, 2 or 3;

n is 1, 2 or 3;

r is 1 or 2;

Y is CR5 or N;

X is O, CHR6, C(R66)(R67), NR7 or C═O;

Z is O or

Z forms with R9a 5 or 6 membered heterocyclyl optionally substituted by R91;

R5 is H or (1-6C)alkyl optionally substituted with one or more fluoro;

R6 is R61, R62, R63, R65, H, hydroxy or fluoro;

R7 is R71, R72, R73, R74 or H;

R8 is heteroaryl, optionally substituted with one or more groups selected from (1-4C)alkyl, hydroxy, (1-6C)alkoxy, amino, (di)[(1-4C)alkyl]amino, [(1-4C)alkyl]amino or halogen;

R9 is H or (1-6C)alkyl optionally substituted with one or more fluoro;

R61 is (1-6C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl(1-3C)alkyl, amino(1-4C)alkyl, [(1-6C)alkyl]amino(1-4C)alkyl, (di)[(1-6C)alkyl]amino(1-4C)alkyl, [(1-4C)alkylcarbonyl]amino(1-4C)alkyl, [(1-4C)alkyl][(1-4C)alkylcarbonyl]amino(1-4C)alkyl, [(1-4C)alkoxycarbonyl]amino(1-4C)alkyl or [(1-4C)alkyl][(1-4C)alkoxycarbonyl]amino(1-4C)alkyl, all of the alkyl groups of R61 are optionally substituted with one or more fluoro;

R62 is (1-6C)alkoxy, hydroxy(1-6-C)alkoxy, (1-3C)alkoxy(2-4C)alkoxy, R621-(2-4C)alkoxy, (1-4C)alkylcarbonyloxy, (1-4C)alkylaminocarbonyloxy or (3-6C)cycloalkylaminocarbonyloxy, all of the alkyl groups of R62 are optionally substituted with one or more fluoro;

R63 is amino, [(1-6C)alkyl]amino, (di)[(1-6C)alkyl]amino, [hydroxy(2-6C)alkyl]amino, [(1-6C)alkyl][hydroxy(2-6C)alkyl]amino, (1-6C)alkoxycarbonylamino, (1-6C)alkylaminocarbonylamino, [(1-6C)alkoxy(2-6C)alkyl]amino, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]amino, (1-6C)alkylcarbonylamino or [(1-6C)alkylcarbonyl][(1-6C)alkoxy(2-6C)alkyl]amino, all of the alkyl groups of R63 are optionally substituted with one or more fluoro;

R65 is N-attached heterocyclyl which is optionally substituted with one or more oxo, fluoro or one or more R651;

R66 is (1-6C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl(1-3C)alkyl, amino(1-4C)alkyl, [(1-6C)alkyl]amino(1-4C)alkyl, (di)[(1-6C)alkyl]amino(1-4C)alkyl, [(1-4C)alkylcarbonyl]amino(1-4C)alkyl, [(1-4C)alkyl][(1-4C)alkylcarbonyl]amino(1-4C)alkyl, [(1-4C)alkoxycarbonyl]amino(1-4C)alkyl, [(1-4C)alkyl][(1-4C)alkoxycarbonyl]amino(1-4C)alkyl, all of the alkyl groups of R66 are optionally substituted with one or more fluoro;

R67 is hydroxy, (1-4C)alkoxy or fluoro;

R71 is (1-6C)alkyl, (3-6C)cycloalkyl or (3-6C)cycloalkyl(1-3C)alkyl, any of which is optionally substituted with one or more fluoro;

R72 is (1-4C)alkyl, which is substituted with one group selected from R721, R722, R724 and R725;

R73 is R732-carbonyl, R733-carbonyl, or R735-carbonyl;

R74 is heterocyclyl which is optionally substituted with one or more groups independently selected from fluoro or R741;

R91 is (1-6C)alkyl optionally substituted with one or more fluoro;

R621 is amino, [(1-6C)alkyl]amino, (di)[(1-6C)alkyl]amino, any of the alkyl groups is optionally substituted with one or more fluoro; or

R621 is N-attached heterocyclyl, optionally substituted with one or more fluoro;

R651 is (1-4C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl(1-3C)alkyl or (1-4C)alkylcarbonyl, all of the alkyl groups of R651 are optionally substituted with one or more groups independently selected from fluoro or hydroxy;

R721 is (1-6C)alkoxy, (3-6C)cycloalkoxy, (1-6C)alkoxy-(3-6C)cycloalkyl, (1-3C)alkoxy(2-4C)alkoxy, amino(2-4C)alkoxy, [(1-6C)alkyl]amino(2-4C)alkoxy, (di)[(1-6C)alkyl]amino(2-4C)alkoxy, [hydroxy(2-6C)alkyl]amino(2-4C)alkoxy, [(1-6C)alkyl][hydroxy(2-6C)alkyl]amino(2-4C)alkoxy, [(1-6C)alkoxy(2-6C)alkyl]amino(2-4C)alkoxy, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]amino(2-4C)alkoxy, (cyclyl-N)-(2-4C)alkoxy, [(1-6C)alkylcarbonyl]amino(1-6C)alkoxy, [(1-6C)alkyl][(1-6C)alkylcarbonyl]amino(1-6C)alkoxy, [(3-6C)cycloalkylcarbonyl]amino(1-6C)alkoxy, [(1-6C)alkyl][(3-6C)cycloalkylcarbonyl]amino(1-6C)alkoxy, aminocarbonyl(1-6C)alkoxy, [(1-6C)alkyl]aminocarbonyl(1-6C)alkoxy, (di)[(1-6C)alkyl]aminocarbonyl(1-6C)alkoxy, [hydroxy(1-6C)alkyl]aminocarbonyl(1-6C)alkoxy or (cyclyl-N)carbonyl(1-6C)alkoxy, all of the alkyl groups of R721 are optionally substituted with one or more groups independently selected from fluoro or hydroxy;

R722 is amino, [(1-6C)alkyl]amino, (di)[(1-6C)alkyl]amino, [hydroxy(2-6C)alkyl]amino, [(1-6C)alkyl][hydroxy(2-6C)alkyl]amino, [(1-6C)alkoxy(2-6C)alkyl]amino, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]amino or cyclyl-N, all of the alkyl groups of R722 are optionally substituted with one or more fluoro;

R724 is (1-6C)alkoxycarbonylamino, [(1-6C)alkoxycarbonyl(1-6C)alkyl]amino, (1-6C)alkylaminocarbonylamino, (cyclyl-N)carbonylamino;

R725 is aminocarbonyl, [(1-6C)alkyl]aminocarbonyl, (di)[(1-6C)alkyl]aminocarbonyl, [hydroxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkyl][hydroxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkoxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]aminocarbonyl, (cyclyl-N)carbonyl, amino(2-4C)alkoxycarbonyl or [(1-6C)alkyl]amino(2-4C)alkoxycarbonyl, all of the alkyl groups of R725 are optionally substituted with one or more fluoro;

R732 is (1-4C)alkyl, amino(1-4C)alkyl, [(1-6C)alkyl]amino(1-4C)alkyl, (di)[(1-6C)alkyl]amino(1-4C)alkyl, [hydroxy(2-6C)alkyl]amino(1-4C)alkyl, [(1-6C)alkyl][hydroxy(2-6C)alkyl]amino(1-4C)alkyl, [(1-6C)alkoxy(2-6C)alkyl]amino(1-4C)alkyl, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]amino(1-4C)alkyl, (cyclyl-N)(1-4C)alkyl, [(1-6C)alkylcarbonyl]amino(1-4C)alkyl, [(1-6C)alkyl][(1-6C)alkylcarbonyl]amino(1-4C)alkyl, hydroxy(1-4C)alkyl, (1-6C)alkoxy(1-4C)alkyl, (3-6C)cycloalkoxy(1-4C)alkyl, aminocarbonyl(1-4C)alkyl, [(1-6C)alkyl]aminocarbonyl(1-4C)alkyl, (di) [(1-6C)alkyl]aminocarbonyl(1-4C)alkyl, [hydroxy(1-6C)alkyl]aminocarbonyl(1-4C)alkyl, [(1-6C)alkyl][hydroxy(1-6C)alkyl]aminocarbonyl(1-4C)alkyl or [(1-6C)alkoxy(2-6C)alkyl]aminocarbonyl(1-4C)alkyl, all of the alkyl groups of R732 are optionally substituted with one or more fluoro;

R733 is (1-6C)alkoxy;

R735 is amino, [(1-6C)alkyl]amino, (di)[(1-6C)alkyl]amino or cyclyl-N, all of the alkyl groups of R735 are optionally substituted with one or more fluoro;

R741 is (1-4C)alkyl, (3-6C)cycloalkyl, (3-6C)cycloalkyl(1-3C)alkyl, (1-6C)alkoxy or (1-4C)alkylcarbonyl all, of the alkyl groups of R741 are optionally substituted with one or more fluoro or hydroxy.

2. The compound according to claim 1 wherein R1 is one or two groups independently selected from hydrogen, hydroxy, (1-3C)alkoxy or halogen.

3. The compound according to claim 2 wherein

R3 is (R31)(R32)CH—O;

R31 is (1-5C)alkyl optionally substituted with hydroxy; and

R32 is (1-5C)alkyl.

4. The compound according to claim 2 wherein

R3 is heteroaryl, which is optionally substituted with one or more groups selected from R34, R35, R36, fluoro, chloro or hydroxy;

R34 is (1-6C)alkyl;

R35 is (1-6C)alkoxy; and

R36 is hydrogen or (1-6C)alkyl.

5. The compound according to claim 4 wherein the heteroaryl group in R3 is

wherein

A is O or NR36 and wherein each C is optionally substituted with one group selected from R34, R35 and fluoro;

R34 is (1-6C)alkyl;

R35 is (1-6C)alkoxy; and

R36 is hydrogen or (1-6C)alkyl.

6. The compound according to claim 5 wherein

R4 is

wherein

R62, when present, is (1-6C)alkoxy, hydroxy(1-6C)alkoxy, (1-3C)alkoxy(2-4C)alkoxy, (1-4C)alkylcarbonyloxy, (1-4C)alkylaminocarbonyloxy, or (3-6C)cycloalkylaminocarbonyloxy, all of the alkyl groups of R62 are optionally substituted with one or more fluoro;

R72, when present, is (1-4C)alkyl, which is substituted with R725; and

R725, when present, is aminocarbonyl, [(1-6C)alkyl]aminocarbonyl, (di)[(1-6C)alkyl]aminocarbonyl, [hydroxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkyl][hydroxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkoxy(2-6C)alkyl]aminocarbonyl, [(1-6C)alkyl][(1-6C)alkoxy(2-6C)alkyl]aminocarbonyl, (cyclyl-N)carbonyl, amino(2-4C)alkoxycarbonyl, or [(1-6C)alkyl]amino(2-4C)alkoxycarbonyl, all of the alkyl groups of R725 are optionally substituted with one or more fluoro.

7. The compound according to claim 6 wherein

R4 is

wherein

m is 1 or 2;

n is 1 or 2;

Y is CR5;

X is O, CHR6 or NR7;

R5 is H;

R6 is R61, R63 or R65;

R7 is R71, R72, R73, R74 or H;

R61 is amino(1-3C)alkyl, [(1-3C)alkyl]amino(1-3C)alkyl, (di)[(1-3C)alkyl]amino(1-3C)alkyl, [(1-3C)alkylcarbonyl]amino(1-3C)alkyl, or [(1-3C)alkoxycarbonyl]amino(1-3C)alkyl;

R63 is amino, [(1-3C)alkyl]amino, (di)[(1-3C)alkyl]amino, [(1-3C)alkoxy(2-3C)alkyl]amino, [(1-3C)alkyl][(1-3C)alkoxy(2-3C)alkyl]amino, or [(1-3C)alkylcarbonyl][(1-3C)alkoxy(2-3C)alkyl]amino, all of the alkyl groups of R63 are optionally substituted with one or more fluoro;

R65 is azetidine, pyrrolidine, piperidine, piperazine or morpholine which is optionally substituted with one or more oxo, fluoro or one or more R651;

R71 is (1-3C)alkyl;

R72 is (1-4C)alkyl, which is substituted with R725;

R73 is R732-carbonyl, R733-carbonyl, or R735-carbonyl;

R74 is pyran or piperidine optionally substituted with one or more groups independently selected from fluoro or R741;

R651 is (1-3C)alkyl, or (1-3C)alkylcarbonyl;

R725 is (di)[(1-3C)alkyl]aminocarbonyl;

R732 is (1-4C)alkyl, amino(1-4C)alkyl, (di)[(1-6C)alkyl]amino(1-4C)alkyl, [hydroxy(2-6C)alkyl]amino(1-4C)alkyl, hydroxy(1-4C)alkyl, or (1-6C)alkoxy(1-4C)alkyl;

R733 is (1-6C)alkoxy;

R735 is amino; and

R741 is (1-4C)alkylcarbonyl.

8. The compound according to claim 5 wherein

R4 is

wherein

m is 1, 2 or 3;

r is 1 or 2;

Z is O or

Z forms with R9a 5 or 6 membered heterocyclyl optionally substituted by R91;

R9 is H or (1-6C)alkyl optionally substituted with one or more fluoro; and

R91 is (1-6C)alkyl optionally substituted with one or more fluoro.

9. The compound according to claim 8 wherein

R4 is

wherein

m is 1 or 2;

r is 1 or 2;

Z is O; and

R9 is H or (1-3C)alkyl.

10. The compound according to claim 5 wherein R4 is (1-4C)alkyl, optionally substituted independently by one or more substituents from R8, or hydroxy, wherein R8 is heteroaryl.

11. The Compound according to claim 1 selected from the group consisting of

N-[2-Methoxy-4-[8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazine]phenyl]-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((Trans)-4-(4-acetylpiperazin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 4-(3-(azetidin-1-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-pentan-2-yl 4-(3-((R)-1-(2-(dimethylamino)acetyl)pyrrolidin-3-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(Trans)-4-(1-(3-methoxy-4-(4-methoxy-1-methyl-1H-indole-2-carboxamido)phenyl)-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl acetate,

N-(4-(3-((trans)-4-hydroxycyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((cis)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((cis)-4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 2-methoxy-4-(3-((trans)-4-(2-methoxyethylamino)cyclohexyl)-8-methyl-imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate, N-(2-methoxy-4-(8-methyl-3-((trans)-4-morpholinocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(3-methyloxetan-3-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(hydroxymethyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((1H-imidazol-1-yl)methyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(1-(tetrahydro-2H-pyran-4-yl)azetidin-3-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(piperidin-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(1-(2-(dimethylamino)-2-oxoethyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(1-(2-Aminoacetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(1-carbamoylpiperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

Methyl 4-(1-(3-methoxy-4-(4-methoxy-1-methyl-1H-indole-2-carboxamido)phenyl)-8-methylimidazo[1,5-a]pyrazin-3-yl)piperidine-1-carboxylate,

N-(2-methoxy-4-(8-methyl-3-(4-methylpiperazin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(2-methoxy-4-(8-methyl-3-(morholin-4-yl) imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

Isopropyl 2-methoxy-4-(8-methyl-3-(4-morpholinopiperidin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-Pentan-2-yl 2-methoxy-4-(3-((trans)-4-((2-methoxyethyl)(methyl)amino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

N-(4-(3-((Trans)-4-(dimethylamino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(3-((cis)-4-((2-methoxyethyl)(methyl)amino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide, 4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((cis)-4-morpholinocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((Cis)-4-(dimethylamino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 4-(3-((cis)-4-(4-acetylpiperazin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-Pentan-2-yl 4-(3-((cis)-4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-Pentan-2-yl 2-methoxy-4-(8-methyl-3-((1r,3r)-3-(4-methylpiperazin-1-yl)cyclobutyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-Pentan-2-yl 2-methoxy-4-(8-methyl-3-(3-(4-methylpiperazin-1-yl)cyclopentyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-Pentan-2-yl 2-methoxy-4-(3-((trans)-4-(N-(2-methoxyethyl)acetamido)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(1-(tetrahydro-2H-pyran-4-yl)piperidin-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 4-(3-(4-acetylpiperazin-1-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

N-(4-(3-(4-(1-Acetylpiperidin-4-yl)piperazin-1-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

N-(2-Methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide 2,2,2-trifluoroacetate,

N-(4-(3-((Trans)-4-(4-acetylpiperazin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 4-(3-((trans)-4-(4-acetylpiperazin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(R)—N-(4-(3-(1-(2-(Dimethylamino)acetyl)pyrrolidin-3-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 2-methoxy-4-(8-methyl-3-((cis)-4-(4-methylpiperazin-1-yl)cyclohexyl) imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

N-(4-(3-(4-Acetylpiperazin-1-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(4-(tetrahydro-2H-pyran-4-yl)piperazin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(R)-4-methoxy-N-(2-methoxy-4-(8-methyl-3-(1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(1-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(1-methyl-2-oxopiperidin-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-aminocyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-(2,2-Difluoroethylamino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

Isopropyl 4-(3-((trans)-4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl(methyl)carbamate,

5-Methoxy-N-(2-methoxy-4-(8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1H-pyrrolo[3,2-b]pyridine-2-carboxamide,

N-(2-Methoxy-4-(8-methyl-3-(1-methylpiperidin-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-4-Hydroxybutan-2-yl 2-methoxy-4-(8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

4-Fluoro-N-(2-methoxy-4-(8-methyl-3-(1-methylpiperidin-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(5-Fluoro-2-methoxy-4-(8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

5-Hydroxypentan-2-yl 5-fluoro-2-methoxy-4-(8-methyl-3-(tetrahydro-2h-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-sec-Butyl 2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

N-(4-(3-(1′-acetyl-1,4′-bipiperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 2-methoxy-4-(3-((S)-1-(2-methoxyacetyl)pyrrolidin-3-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(trans)-4-(1-(3-Methoxy-4-(4-methoxy-1-methyl-1H-indole-2-carboxamido)phenyl)-8-methylimidazo[1,5-a]pyrazin-3-yl)cyclohexyl cyclopentylcarbamate,

(R)—N-(4-(3-(1-(2-(dimethylamino)-2-oxoethyl)pyrrolidin-3-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(R)—N-(4-(3-(1-(2-hydroxyacetyl)pyrrolidin-3-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(piperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Chloro-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-pyrrole-2-carboxamide,

N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-6-methyl-6H-thieno[2,3-b]pyrrole-5-carboxamide,

N-(2-Methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-6H-thieno[2,3-b]pyrrole-5-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1H-indole-2-carboxamide,

4-Hydroxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 4-(3-((trans)-4-(aminomethyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

1-Methyl-N-(4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1H-indole-2-carboxamide,

N-(2-hydroxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-((methylamino)methyl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-((dimethylamino)methyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-Pentan-2-yl 4-(3-((trans)-4-((dimethylamino)methyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

6-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1H-indazole-3-carboxamide,

5-Chloro-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxamide,

N-(4-(3-((trans)-4-(acetamidomethyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 4-(3-((trans)-4-(acetamidomethyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-pentan-2-yl 4-(3-((trans)-4-(methoxycarbonylmethyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(4-oxocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-hydroxy-4-((methylamino)methyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-(1-methyl-5-oxopyrrolidin-3-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

5-Methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-pyrrolo[2,3-c]pyridine-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-4-morpholinocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-((trans)-4-morpholinocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-pentan-2-yl 4-(3-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-pentan-2-yl 4-(3-(1-(2-(dimethylamino)-2-oxoethyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-morpholinoimidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

isopropyl 2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

4-fluoro-N-(2-methoxy-4-(8-methyl-3-(tetrahydro-2H-pyran-4-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

tert-butyl 2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

N-(4-(3-(1-(2-(dimethylamino)-2-oxoethyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(azetidin-1-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide,

5-hydroxypentan-2-yl 2-methoxy-4-(8-methyl-3-((trans)-4-(4-methylpiperazin-1-yl)cyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-pentan-2-yl 4-(3-(1-(2-aminoacetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

N-(4-(3-(1-(2-aminoacetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-((trans)-4-(aminomethyl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-((cis)-4-morpholinocyclohexyl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-(4-morpholinopiperidin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate,

4-methoxy-N-(2-methoxy-4-(8-methyl-3-(4-morpholinopiperidin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(8-methyl-3-((trans)-3-(4-methylpiperazin-1-yl)cyclobutyl)imidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(3-((trans)-4-(2-methoxyethylamino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(3-((trans)-4-(N-(2-methoxyethyl)acetamido)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(8-methyl-3-morpholinoimidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

4-methoxy-N-(2-methoxy-4-(3-((trans)-4-((2-methoxyethyl)(methyl)amino)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)phenyl)-1-methyl-1H-indole-2-carboxamide,

N-(4-(3-(1-(2-(dimethylamino)acetyl)piperidin-4-yl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-4-methoxy-1-methyl-1H-indole-2-carboxamide,

(S)-pentan-2-yl 4-(3-((trans)-4-(3,3-difluoroazetidin-1-yl)cyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenylcarbamate,

(S)-pentan-2-yl 2-methoxy-4-(8-methyl-3-(4-(tetrahydro-2H-pyran-4-yl)piperazin-1-yl)imidazo[1,5-a]pyrazin-1-yl)phenylcarbamate, and

N-(4-(3-((trans)-4-(3,3-difluoroazetidin-1-ypcyclohexyl)-8-methylimidazo[1,5-a]pyrazin-1-yl)-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide.

12. A method of modulating lymphocite specific kinase activity in a subject comprising administering to the subject an amount of a compound of claim 1 .